The Ministry of Health, in collaboration with the World Health Organization (WHO) and Health Action International Africa (HAI-Africa) represented by the Coalition for Health Promotion and Social Development (HEPS-Uganda), conducts quarterly surveys on medicine prices and availability in the four major geographical regions of the country. This is part of monitoring the ongoing interventions by the Ministry of Health within the second Health Sector Strategic Plan (HSSP II) to increase access to essential medicines for all Ugandans.
This report summarizes the findings for the survey conducted in the fourth quarter of 2008.
Key Findings: Overall
- Compared to the findings of the July-September 2008 survey, there was an increase in the overall medicine availability in the private (9%) and public (4%) sector and a decline in the mission sector (6%).
- Availability of Artemether-Lumefantrine, the first line antimalarial, was highest in the mission sector at 96%, followed by the public sector at 75%, while it was low in the private sector facilities at 28%.
- For most medicines in private sector and mission facilities remained unaffordable for the majority of the population in Uganda where 31% live in poverty.1
- Availability of paediatric formulations has been consistently below 30% in the public sector, and availability of medicines for chronic diseases was very poor.